Vaxcyte prices $1 billion dual offering of stock and notes

Markets Investing.com By Investing.com 07 Oct 2026 02:52 1 min read
Vaxcyte prices $1 billion dual offering of stock and notes

Covered in this story

Analyst targets on Vaxcyte Inc

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $PCVX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Vaxcyte Inc →

Dalsna Finance is currently tracking 7 stories mentioning Vaxcyte Inc, the earliest published 5 Oct 2026.

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.